Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Clinical value of suPAR, a new critical biomarker — Katia Donadello (2011) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Clinical value of suPAR, a new critical biomarker
Shared by
Jean Louis Vincent
Université Libre de Bruxelles
Clinical value of suPAR, a new critical biomarker
Article
2011
en
Authors
+7 more
KD
Katia Donadello
CC
Cecilia Covajes
SS
Sabino Scolletta
Abstract
1 min read
info:eu-repo/semantics/published
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2011
Clinical value of SuPAR in patients with septic shock
Katia Donadello
,
Cecilia Covajes
,
Sabino Scolletta
,
Fabio Taccone
,
Cristina Santonocito
,
Serge Brimioulle
,
Marjorie Beumier
,
Marc Van Nuffelen
,
Leonardo Gottin
,
Jean Louis Vincent
Article
1999
Drugs in the critical illness – Vasoconstrictors
Jean Louis Vincent
,
Andrew Webb
,
M.J. Shapiro
,
Mendel E. Singer
,
Peter M. Suter
Article
2009
Risk/benefit ratios in critical care decisions
Jean Louis Vincent
,
Diamantino Salgado
,
Charalampos Pierrakos
,
Jean‐Daniel Chiche
,
Rui P. Moreno
,
Christian Putensen
,
Andrews Rhodes
Article
1984
A new portable system for transportation of critically ill patients with cardiopulmonary failure
Jean Louis Vincent
,
Philippe Dufaye
,
Robert J. Kahn
Article
1991
New aspects of inodilating therapy
Jean Louis Vincent
Discussion(0)
No comments yet. Be the first to comment.